Trials / Conditions / Advanced Lung Carcinoma

Advanced Lung Carcinoma

17 registered clinical trials studyying Advanced Lung Carcinoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079	TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)	Phase 1
Recruiting	Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, He NCT05705492	OHSU Knight Cancer Institute	Phase 2
Recruiting	Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer NCT06343402	TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)	Phase 1
Not Yet Recruiting	Exercise in Patients With Advanced Non-small Cell Lung Cancer NCT06374160	University Hospital, Essen	N/A
Recruiting	At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860	Mayo Clinic	Phase 2
Terminated	A Biomarker Screening Protocol for Participants With Solid Tumors NCT05891197	Lyell Immunopharma, Inc.	—
Active Not Recruiting	Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With E NCT05256290	Black Diamond Therapeutics, Inc.	Phase 1 / Phase 2
Terminated	A Study to Investigate LYL797 in Adults With Solid Tumors NCT05274451	Lyell Immunopharma, Inc.	Phase 1
Terminated	A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy S NCT04924192	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Phase 2
Completed	A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer NCT05342571	Ohio State University Comprehensive Cancer Center	N/A
Terminated	Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metasta NCT04785287	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	A Nurse-Led Intervention for Fear of Progression in Advanced Cancer NCT04819997	City of Hope Medical Center	N/A
Completed	BeWell360-CG Care Model: Health and Wellness Coaching to Support Caregivers of Patients Living With Advanced L NCT05640765	Mayo Clinic	N/A
Unknown	Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bro NCT04702009	Shanghai Pulmonary Hospital, Shanghai, China	Phase 2 / Phase 3
Completed	Resiliency Among Older Adults Receiving Lung Cancer Treatment NCT04229381	Ohio State University Comprehensive Cancer Center	N/A
Active Not Recruiting	Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung NCT03707938	M.D. Anderson Cancer Center	Phase 1
Completed	Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer NCT03776253	City of Hope Medical Center	N/A